Home•Our Research•Publications•Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study

Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study

Thematic Area:
Digital Health
Disease Area:
Epilepsy
Research Focus:
BiomarkersHealth Data Analytics
Collaborators:
AcademicClinical